Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis.

Grossmann ME, Yang DQ, Guo Z, Potter DA, Cleary MP.

Curr Pharmacol Rep. 2015 Apr 1;1(5):312-323.

2.

Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet.

Zhang Y, Li Q, Rao E, Sun Y, Grossmann ME, Morris RJ, Cleary MP, Li B.

Immunity. 2015 May 19;42(5):953-964. doi: 10.1016/j.immuni.2015.04.016.

3.

Combination of intermittent calorie restriction and eicosapentaenoic acid for inhibition of mammary tumors.

Mizuno NK, Rogozina OP, Seppanen CM, Liao DJ, Cleary MP, Grossmann ME.

Cancer Prev Res (Phila). 2013 Jun;6(6):540-7. doi: 10.1158/1940-6207.CAPR-13-0033. Epub 2013 Apr 2.

4.

Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity.

Bonorden MJ, Grossmann ME, Ewing SA, Rogozina OP, Ray A, Nkhata KJ, Liao DJ, Grande JP, Cleary MP.

Prostate Cancer. 2012;2012:543970. doi: 10.1155/2012/543970. Epub 2012 Dec 4.

5.

The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Grossmann ME, Cleary MP.

Biochimie. 2012 Oct;94(10):2164-71. doi: 10.1016/j.biochi.2012.06.013. Epub 2012 Jun 20. Review.

6.

The manner in which calories are restricted impacts mammary tumor cancer prevention.

Cleary MP, Grossmann ME.

J Carcinog. 2011;10:21. doi: 10.4103/1477-3163.85181. Epub 2011 Sep 21.

7.

Obesity and breast cancer: status of leptin and adiponectin in pathological processes.

Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP.

Cancer Metastasis Rev. 2010 Dec;29(4):641-53. doi: 10.1007/s10555-010-9252-1. Review.

PMID:
20821253
8.

Effect of obesity on breast cancer development.

Cleary MP, Grossmann ME, Ray A.

Vet Pathol. 2010 Mar;47(2):202-13. doi: 10.1177/0300985809357753. Epub 2010 Feb 1. Review.

PMID:
20124008
9.

Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation.

Grossmann ME, Mizuno NK, Schuster T, Cleary MP.

Int J Oncol. 2010 Feb;36(2):421-6.

PMID:
20043077
10.

Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism.

Grossmann ME, Mizuno NK, Dammen ML, Schuster T, Ray A, Cleary MP.

Cancer Prev Res (Phila). 2009 Oct;2(10):879-86. doi: 10.1158/1940-6207.CAPR-09-0088. Epub 2009 Sep 29.

11.

Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention.

Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME.

Front Biosci (Schol Ed). 2009 Jun 1;1:329-57. Review.

PMID:
19482706
12.

Effects of adiponectin and leptin co-treatment on human breast cancer cell growth.

Nkhata KJ, Ray A, Schuster TF, Grossmann ME, Cleary MP.

Oncol Rep. 2009 Jun;21(6):1611-9.

PMID:
19424644
13.

Minireview: Obesity and breast cancer: the estrogen connection.

Cleary MP, Grossmann ME.

Endocrinology. 2009 Jun;150(6):2537-42. doi: 10.1210/en.2009-0070. Epub 2009 Apr 16. Review.

14.

Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice.

Bonorden MJ, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, Perkins S, Lokshin A, Cleary MP.

Nutr Cancer. 2009;61(2):265-75. doi: 10.1080/01635580802419798.

PMID:
19235043
15.

PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.

Vanaja DK, Grossmann ME, Cheville JC, Gazi MH, Gong A, Zhang JS, Ajtai K, Burghardt TP, Young CY.

Cancer Invest. 2009 Mar;27(3):264-72. doi: 10.1080/07357900802406319.

16.

Role of the adiponectin leptin ratio in prostate cancer.

Grossmann ME, Mizuno NK, Bonorden MJ, Ray A, Sokolchik I, Narasimhan ML, Cleary MP.

Oncol Res. 2009;18(5-6):269-77.

PMID:
20225764
17.

Cross-sectional analysis of intermittent versus chronic caloric restriction in the TRAMP mouse.

Bonorden MJ, Rogozina OP, Kluczny CM, Grossmann ME, Grande JP, Lokshin A, Cleary MP.

Prostate. 2009 Feb 15;69(3):317-26. doi: 10.1002/pros.20878.

PMID:
19016490
18.

Balance of adiponectin and leptin modulates breast cancer cell growth.

Grossmann ME, Ray A, Dogan S, Mizuno NK, Cleary MP.

Cell Res. 2008 Nov;18(11):1154-6. doi: 10.1038/cr.2008.293. No abstract available.

PMID:
18957939
19.

Effects of adiponectin on breast cancer cell growth and signaling.

Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP.

Br J Cancer. 2008 Jan 29;98(2):370-9. doi: 10.1038/sj.bjc.6604166. Epub 2008 Jan 8.

20.

Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response?

Cleary MP, Hu X, Grossmann ME, Juneja SC, Dogan S, Grande JP, Maihle NJ.

Exp Biol Med (Maywood). 2007 Jan;232(1):70-80.

PMID:
17202587
21.

Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo.

Grossmann ME, Madden BJ, Gao F, Pang YP, Carpenter JE, McCormick D, Young CY.

Exp Cell Res. 2004 Jul 1;297(1):108-17.

PMID:
15194429
22.
23.

Expression, specificity and immunotherapy potential of prostate-associated genes in murine cell lines.

Grossmann ME, Wood M, Celis E.

World J Urol. 2001 Nov;19(5):365-70.

PMID:
11760786
24.

Androgen receptor signaling in androgen-refractory prostate cancer.

Grossmann ME, Huang H, Tindall DJ.

J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97. Review.

PMID:
11717329
25.

Avoiding Tolerance Against Prostatic Antigens With Subdominant Peptide Epitopes.

Grossmann ME, Davila E, Celis E.

J Immunother (1991). 2001 May;24(3):237-241.

PMID:
11395639
26.

Avoiding tolerance against prostatic antigens with subdominant peptide epitopes.

Grossmann ME, Davila T, Celis T.

J Immunother. 2001 May-Jun;24(3):237-41.

PMID:
11394501
28.

Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene.

Kumar MV, Jones EA, Felts SJ, Blexrud MD, Grossmann ME, Blok LJ, Schmidt LJ, Tindall DJ.

J Androl. 1998 Sep-Oct;19(5):595-602.

29.

Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line.

Perry JE, Grossmann ME, Tindall DJ.

Prostate. 1998 May;35(2):117-24.

PMID:
9568675
30.

Antitumor responses induced by transgenic expression of CD40 ligand.

Grossmann ME, Brown MP, Brenner MK.

Hum Gene Ther. 1997 Nov 1;8(16):1935-43.

PMID:
9382959
31.

Gene marking and gene therapy for transplantation medicine.

Dilloo D, Rill DR, Grossmann ME, Leimig T, Brenner MK.

J Hematother. 1996 Oct;5(5):553-5. Review.

PMID:
8938528
32.

Androgen regulation of gene expression.

Perry JE, Grossmann ME, Tindall DJ.

Prostate Suppl. 1996;6:79-81. Review.

PMID:
8630235
33.
34.
35.

The mouse androgen receptor gene contains a second functional promoter which is regulated by dihydrotestosterone.

Grossmann ME, Lindzey J, Blok L, Perry JE, Kumar MV, Tindall DJ.

Biochemistry. 1994 Dec 6;33(48):14594-600.

PMID:
7981221
36.

Identification and characterization of a suppressor element in the 5'-flanking region of the mouse androgen receptor gene.

Kumar MV, Jones EA, Grossmann ME, Blexrud MD, Tindall DJ.

Nucleic Acids Res. 1994 Sep 11;22(18):3693-8.

37.

The mouse androgen receptor is suppressed by the 5'-untranslated region of the gene.

Grossmann ME, Lindzey J, Kumar MV, Tindall DJ.

Mol Endocrinol. 1994 Apr;8(4):448-55.

PMID:
8052266
38.

Experience with new contrast media for hysterosalpingography.

REISS HE, GROSSMANN ME.

J Obstet Gynaecol Br Emp. 1958 Oct;65(5):782-7. No abstract available.

PMID:
13588436
39.

Direct placentography.

GROSSMANN ME.

Br J Radiol. 1953 Aug;26(308):388-92. No abstract available.

PMID:
13059323
40.

The role of radiology in obstetrics.

GROSSMANN ME.

Practitioner. 1947 Jul;159(949):22-8. No abstract available.

PMID:
20248477

Supplemental Content

Loading ...
Support Center